0000899243-22-021918.txt : 20220610 0000899243-22-021918.hdr.sgml : 20220610 20220610163051 ACCESSION NUMBER: 0000899243-22-021918 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220608 FILED AS OF DATE: 20220610 DATE AS OF CHANGE: 20220610 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Golumbeski George CENTRAL INDEX KEY: 0001586660 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39593 FILM NUMBER: 221009342 MAIL ADDRESS: STREET 1: C/O CELGENE CORP. STREET 2: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Shattuck Labs, Inc. CENTRAL INDEX KEY: 0001680367 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 812575858 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 W. 5TH STREET CITY: AUSTIN STATE: TX ZIP: 78701 BUSINESS PHONE: 512-900-4690 MAIL ADDRESS: STREET 1: 500 W. 5TH STREET CITY: AUSTIN STATE: TX ZIP: 78701 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-06-08 0 0001680367 Shattuck Labs, Inc. STTK 0001586660 Golumbeski George C/O SHATTUCK LABS, INC. 500 W. 5TH STREET, SUITE 1200 AUSTIN TX 78701 1 0 0 0 Stock Option (Right to Buy) 4.32 2022-06-08 4 A 0 40258 0.00 A 2032-06-08 Common Stock 40258 40258 D This option represents a right to purchase a total of 40,258 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer. /s/ Erin Ator Thomson, Attorney-in-Fact for George Golumbeski 2022-06-10